Cross-linking of fibrin by fibrin=stabilizing factor

May 28, 2005·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Wolfhart KreuzRudolf Egbring

Efficacy and tolerability of a pasteurised human fibrinogen concentrate in patients with congenital fibrinogen deficiency

May 28, 2005·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Wolfhart KreuzRudolf Egbring

Fibrin precursors, intermediaries for hemostasis in the clot war

Feb 28, 2002·Thrombosis Research·J R Shainoff, Patricia M DiBello

Postsurgical hemorrhage in dogs anticoagulated with ancrod (Arvin)

Dec 1, 1973·Annals of Surgery·C L SladeP A Mckee

Comparison of ancrod and heparin as anticoagulants following endarterectomy in the dog

Aug 1, 1976·Annals of Surgery·T M DanielP A Mckee

Fibrinogen Cleveland II. An abnormal fibrinogen with defective release of fibrinopeptide A

May 1, 1974·The Journal of Clinical Investigation·E D CrumO D Ratnoff

Fibrinogen Petoskey: identification of a new dysfibrinogenemia characterized by altered release of fibrinopeptide A

Sep 15, 1981·Thrombosis Research·D L HigginsJ A Shafer

Fibrin oligomers of high molecular weight soluble in MCA solutions: implications on the time course of fibrinI formation

Aug 1, 1980·Thrombosis Research·G Reinhardt

Human platelet glycoproteins. Further evidence that the "GP I band" from whole platelets contains three different polypeptides one of which may be involved in the interaction between platelets and Factor VIII

Jan 1, 1977·Thrombosis Research·N O SolumM Peterka

Factor XIII binds to the A alpha- and B beta- chains in the D-domain of fibrinogen: an immunoblotting study

Sep 15, 1987·Biochemical and Biophysical Research Communications·A MaryC S Greenberg

Letter: Thrombosis and myocardial infarction

Jun 1, 1974·Circulation·E W Ferguson

Letter: The fourth heart sound

Jun 1, 1974·Circulation·D H Spodnick

Identification of fibrinogen derivatives in the Triton-insoluble residue of human blood platelets

Jan 1, 1983·Cell Motility·J F CasellaM B Zucker

Impaired plasma clottability induction through fibrinogen degradation by ASP, a serine protease released from Aeromonas sobria

May 9, 2008·FEMS Microbiology Letters·Takahisa ImamuraKeinosuke Okamoto

Fibrinogen: evolution of the structure-function concept. Keynote address at fibrinogen 2000 congress

Jul 20, 2001·Annals of the New York Academy of Sciences·B Blombäck

Loss of fibrinogen in zebrafish results in an asymptomatic embryonic hemostatic defect and synthetic lethality with thrombocytopenia

Jan 22, 2019·Journal of Thrombosis and Haemostasis : JTH·Zhilian HuJordan A Shavit

Functional analysis of fibrin {gamma}-chain cross-linking by activated factor XIII: determination of a cross-linking pattern that maximizes clot stiffness

Apr 17, 2007·Blood·Kristina F StandevenRobert A S Ariëns

Related Concepts

Blood Coagulation

Blood Platelets

SDS-PAGE

Enzyme Activation

Enzyme Precursors

Factor XIII A-Chain

Factor Xiii Deficiency

Antithrombin I

Gamma-Fibrinogen

Fibrinolysis

Related Feeds

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Cross-linking of fibrin by fibrin=stabilizing factor

Abstract

References

Isolation and characterization of the clottable low molecular weight fibrinogen derived by limited plasmin hydrolysis of human fraction I-4

Distribution of carbohydrate among the polypeptide chains and plasmin digest products of human fibrinogen

The initial macromolecular derivatives of human fibrinogen produced by plasmin

Cross-link in fibrin polymerized by factor 13: epsilon-(gamma-glutamyl)lysine

Factor 13 and antiplasmin activity in human platelets

Molecular weight of bovine fibrinogen by sedimentation equilibrium

The effect of fibrin-stabilizing factor on the subunit structure of human fibrin

Hybrid fibrin: proof of the intermolecular nature of - crosslinking units

Subunit structure of human fibrinogen, soluble fibrin, and cross-linked insoluble fibrin

Epsilon-(gamma glutamyl) lysine in fibrin: lack of crosslink formation in Factor 13 deficiency

Factor XIII assay by an isotope method. I. Factor XIII (transamidase) in plasma, serum, leucocytes, erythrocytes and platelets and evaluation of screening tests of clot solubility

The identification of isopeptide crosslinks in insoluble fibrin

The transpeptidase system which crosslinks fibrin by gamma-glutamyle-episilon-lysine bonds

High resolution acrylamide gel electrophoresis of histones

Factor XIII in human plasma and platelets

Physicochemical studies of bovine fibrinogen. I. Molecular weight and hydrodynamic properties of fibrinogen and fibrinogen cleaved by sulfite in 5 M guanidine-HC-l solution

The subunit polypeptides of human fibrinogen

Transglutaminase: mechanistic features of the active site as determined by kinetic and inhibitor studies

Human fibrinogen of relatively high solubility. Comparative biophysical, biochemical, and biological studies with fibrinogen of lower solubility

Crosslinking of human fibrin: Evidence for intermolecular crosslinking involving alpha-chains

Preparation and isolation of the S-carboxymethyl derivative chains of human fibrinogen

The fibrin serum factor

The ribonuclease of Phaseolus aureus Roxb. I. Purification of the enzyme

The separation and isolation of the peptide chains of fibrin

On the Solubility of Fibrin Clots

Citations

An acquired hemorrhagic disorder of fibrin crosslinking due to IgG antibodies to FXIII, successfully treated with FXIII replacement and cyclophosphamide

Analysis of the fibrin-polymerizing reaction using sodium dodecylsulfate-agarose gel electrophoresis

Isolation of the cross link peptide of fibrin

Fibrinogen and fibrin--proteins with complex roles in hemostasis and thrombosis

Structural difference between polymerized and non-polymerized fragment X, obtained by plasmin digest of fibrinogen

Ca2+-dependent cross-linking processes in human platelets

Pharmacokinetic properties of a pasteurised fibrinogen concentrate